| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pqr309 | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] Cells[MeSHID:D002477] |
0.19 | phase 2 | unknown |
| pqr309 | pi3-kinase beta | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] Cells[MeSHID:D002477] |
0.39 | phase 2 | unknown |
| pqr309 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pain[MeSHID:D010146] Cells[MeSHID:D002477] |
0.25 | phase 2 | unknown |
| click here to return to the previous page | ||||||||